◀  Back to Library

Lateral Pharma

Mr David Kenley, CEO

Mr David Kenley

Mr Kenley is the inventor of the OA, pain and other identified potential new applications for the proven safe peptide which has a US GRAS (Generally Recognised As Safe) Status .and backup compounds.

Lateral Pharma Product Development Comparator Drug Supplier

Lateral Pharma commenced operations in May 2015 to repurpose LAT8881, a Phase 2 orally-available compound with extensive toxicology and human safety data, into new high potential indications.

View Company Profile